Dexcom Announces Upcoming Conference Presentation


Werte in diesem Artikel
Aktien

75.80 EUR 2.60 EUR 3.55 %

Werbung

DexCom, Inc. (NASDAQ:DXCM) today announced that Sean Christensen, Vice President, Finance and Investor Relations, will present an update on the company at the 45th Annual Raymond James Institutional Investors Conference on Tuesday, March 5th.

The live presentation is scheduled to begin at approximately 8:40 AM EST and will be concurrently webcast.

Links to the webcast will be available on the DexCom Investor Relations website at investors.dexcom.com and will be archived there for future reference.

Werbung

About DexCom, Inc.

DexCom, Inc. empowers people to take real-time control of health through innovative continuous glucose monitoring systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers, and providers, Dexcom works to simplify and improve diabetes management around the world. For more information on Dexcom, visit www.dexcom.com.

Category: IR

Aktuelle DexCom Aktie News

Werbung

DexCom Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für DexCom nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
02.08.18 DexCom Buy Canaccord Adams
03.05.18 DexCom Buy Canaccord Adams
23.03.18 DexCom Outperform Robert W. Baird & Co. Incorporated
28.09.17 DexCom Outperform Wedbush Morgan Securities Inc.
15.09.17 DexCom Equal Weight Barclays Capital